Published : Jul-2018
No. of Pages : 130
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Hematology Reagents Overview 7
3 Products under Development 8
3.1 Hematology Reagents - Pipeline Products by Stage of Development 8
3.2 Hematology Reagents - Pipeline Products by Segment 9
3.3 Hematology Reagents - Pipeline Products by Territory 10
3.4 Hematology Reagents - Pipeline Products by Regulatory Path 11
3.5 Hematology Reagents - Pipeline Products by Estimated Approval Date 12
4 Hematology Reagents - Pipeline Products under Development by Companies 13
4.1 Hematology Reagents Companies - Pipeline Products by Stage of Development 13
4.2 Hematology Reagents - Pipeline Products by Stage of Development 14
5 Hematology Reagents Companies and Product Overview 15
5.1 Analyticon Biotechnologies AG Company Overview 15
5.2 Cellphire Inc Company Overview 21
5.3 CPSI Biotech Company Overview 22
5.4 Instrumentation Laboratory Company Overview 23
5.5 Quotient Limited Company Overview 26
5.6 Streck Inc Company Overview 30
5.7 University of California Los Angeles Company Overview 34
6 Hematology Reagents- Recent Developments 35
6.1 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 35
6.2 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 35
6.3 Jun 01, 2018: ISBT Satellite Symposium Co-hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics 36
6.4 May 29, 2018: Quotient Names Franz Walt As Chief Executive Officer 37
6.5 May 29, 2018: Quotient Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Updates on CEO Appointment and MosaiQ European Field Trials 38
6.6 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 39
6.7 May 23, 2018: Swift Biosciences Builds on Momentum, Accelerates Growth with Addition of Nathan Wood as New CEO 42
6.8 May 14, 2018: Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents 43
6.9 May 14, 2018: Boule Diagnostics Interim report January - March 2018 43
6.10 May 09, 2018: Accelerate Diagnostics reports Q1 2018 financial results 44
6.11 May 09, 2018: Sysmex Group Formulates New Long-Term Management Goals 45
6.12 May 09, 2018: Sysmex Announces Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 47
6.13 May 08, 2018: Haemonetics Appoints Said Bolorforosh Executive Vice President, Chief Technology Officer 50
6.14 May 08, 2018: Bio-Rad Announces First Quarter 2018 Financial Results 51
6.15 May 08, 2018: Haemonetics Reports 4th Quarter and Fiscal Year 2018 Results and Provides Fiscal 2019 Guidance 51
6.16 May 08, 2018: Ortho Clinical Diagnostics Holds Summit to Help Asia-Pacific Lab Leaders Envision the Lab of the Future 53
6.17 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 53
6.18 May 07, 2018: Instrumentation Laboratory Worldwide Sales Top $970 M In 2017 54
6.19 May 03, 2018: Siemens Healthineers fully on track to meet the targets 55
7 Appendix 127
7.1 Methodology 127
7.2 About GlobalData 130
7.3 Contact Us 130
7.4 Disclaimer 130
1.1 List of Tables
Table 1: Hematology Reagents - Pipeline Products by Stage of Development 8
Table 2: Hematology Reagents - Pipeline Products by Segment 9
Table 3: Hematology Reagents - Pipeline Products by Territory 10
Table 4: Hematology Reagents - Pipeline Products by Regulatory Path 11
Table 5: Hematology Reagents - Pipeline Products by Estimated Approval Date 12
Table 6: Hematology Reagents Companies - Pipeline Products by Stage of Development 13
Table 7: Hematology Reagents - Pipeline Products by Stage of Development 14
Table 8: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 15
Table 9: Fluitest IRON B Reagent - Product Status 15
Table 10: Fluitest IRON B Reagent - Product Description 16
Table 11: Hemolyzer - 5 - Diff 5P - Product Status 16
Table 12: Hemolyzer - 5 - Diff 5P - Product Description 16
Table 13: Hemolyzer - 5 - Diluent - Product Status 17
Table 14: Hemolyzer - 5 - Diluent - Product Description 17
Table 15: Hemolyzer-3-Cleaner - Product Status 17
Table 16: Hemolyzer-3-Cleaner - Product Description 18
Table 17: Hemolyzer-3-Diluent - Product Status 18
Table 18: Hemolyzer-3-Diluent - Product Description 18
Table 19: Hemolyzer-3-Lyser - Product Status 19
Table 20: Hemolyzer-3-Lyser - Product Description 19
Table 21: Hemolyzer-5-Lyser - Product Status 19
Table 22: Hemolyzer-5-Lyser - Product Description 20
Table 23: Turbitex FER Reagent - Product Status 20
Table 24: Turbitex FER Reagent - Product Description 20
Table 25: Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview 21
Table 26: Thrombogent - Product Status 21
Table 27: Thrombogent - Product Description 21
Table 28: CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 22
Table 29: FACSGuard - Product Status 22
Table 30: FACSGuard - Product Description 22
Table 31: Instrumentation Laboratory Company Pipeline Products & Ongoing Clinical Trials Overview 23
Table 32: HemosIL AcuStar Multi-Ab Controls - Product Status 23
Table 33: HemosIL AcuStar Multi-Ab Controls - Product Description 23
Table 34: HemosIL Dabigatran Calibrators - Product Status 24
Table 35: HemosIL Dabigatran Calibrators - Product Description 24
Table 36: HemosIL Dabigatran Controls - Product Status 24
Table 37: HemosIL Dabigatran Controls - Product Description 25
Table 38: HemosIL Rivaroxaban Calibrators - Product Status 25
Table 39: HemosIL Rivaroxaban Calibrators - Product Description 25
Table 40: Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview 26
Table 41: ALBAcyte Antibody Identification Cells - B - Product Status 26
Table 42: ALBAcyte Antibody Identification Cells - B - Product Description 26
Table 43: ALBAcyte Rh - Screening Cells - Product Status 27
Table 44: ALBAcyte Rh - Screening Cells - Product Description 27
Table 45: ALBAcyte Screening Cells (2 cell) - Product Status 27
Table 46: ALBAcyte Screening Cells (2 cell) - Product Description 27
Table 47: Anti-Human C3 Globulin Reagent - Product Status 28
Table 48: Anti-Human C3 Globulin Reagent - Product Description 28
Table 49: Complement Coated Cells - Product Status 28
Table 50: Complement Coated Cells - Product Description 28
Table 51: WARM Antibody Removal Reagent - Product Status 29
Table 52: WARM Antibody Removal Reagent - Product Description 29
Table 53: Streck Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 54: CD-Chex CD103 Plus - Product Status 30
Table 55: CD-Chex CD103 Plus - Product Description 31
Table 56: CD-Chex CD117 Plus - Product Status 31
Table 57: CD-Chex CD117 Plus - Product Description 31
Table 58: CD-Chex Select - Product Status 32
Table 59: CD-Chex Select - Product Description 32
Table 60: CD-Chex TdT Plus - Product Status 32
Table 61: CD-Chex TdT Plus - Product Description 33
Table 62: LBC-Chex - Product Status 33
Table 63: LBC-Chex - Product Description 33
Table 64: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 34
Table 65: Rh (D) Human Blood Typing Reagent - Product Status 34
Table 66: Rh (D) Human Blood Typing Reagent - Product Description 34
Table 67: Glossary 129
1.2 List of Figures
Figure 1: Hematology Reagents - Pipeline Products by Stage of Development 8
Figure 2: Hematology Reagents - Pipeline Products by Segment 9
Figure 3: Hematology Reagents - Pipeline Products by Territory 10
Figure 4: Hematology Reagents - Pipeline Products by Regulatory Path 11
Figure 5: Hematology Reagents - Pipeline Products by Estimated Approval Date 12
